Cannabis Edibles, Efficacy, and Special Populations
Pricing:
- Member: $0.00 - Save 100%
- Student Member: $0.00 - Save 100%
- Non-Member: $9.95
Member Fees will be applied upon check out.
Speaker: Dr. Michael Beazely
School of Pharmacy
University of Waterloo
Cannabis edibles have now been on the regulated Canadian recreational cannabis market for about a year. We will learn about cannabis edibles and other dosage forms. We will also discuss the current best evidence for the use of medical cannabis to treat disease. Special populations will also be discussed, including youth, older adults, patients with renal or liver dysfunction, and pregnancy and lactation.
Learning objectives:
- Compare contrast recreational, medical, and pharmaceutical cannabis dosage forms.
- Demonstrate knowledge about the current state of evidence for the efficacy of cannabinoids to treat disease
- Employ prevention and harm reduction approaches to mitigate harms associated with cannabis use in youth, older adults, and in pregnancy
About the Speaker:
Dr. Michael Beazely is a faculty member at the School of Pharmacy, University of Waterloo. His research lab research focuses on understanding how growth factor receptors and G protein-coupled receptors modulate ion channels and neuronal cell function. Prof. Beazely's clinical research includes the evaluation of undergraduate pharmacy education with respect to substance use and ongoing educational tool development for practicing health professionals. He is interested in assessing interventions by community pharmacists aimed at reducing harms associated with substance use and understanding the intersection between drug use and ongoing pharmaceutical care.** Original Source: "CNS Education Webinars" Wednesday, October 14, 2020
Length:
Type: File
Last Updated: June 18, 2021
| Name | Type |
|---|---|
| Cannabis Edibles, Efficacy, and Special Populations | File |
| Cannabis Edibles, Efficacy, and Special Populations | Video |